Lataa...
Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
INTRODUCTION: Neurogenic orthostatic hypotension (nOH) is associated with neurodegenerative conditions, may cause symptoms of end‐organ hypoperfusion, increases fall risk, and can negatively impact quality of life. Droxidopa is approved for the treatment of symptomatic nOH in adults. As the largest...
Tallennettuna:
| Julkaisussa: | Mov Disord Clin Pract |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277368/ https://ncbi.nlm.nih.gov/pubmed/30637284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12695 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|